Dr Becky Inkster

Becky Inkster

University position

NSPN Senior Manager & Wolfson College Research Associate

Departments

Department of Psychiatry

Email

bi212@medschl.cam.ac.uk

Home page

http://www.hiphoppsych.co.uk/ (personal home page)

Research Themes

Developmental Neuroscience

Systems and Computational Neuroscience

Interests

I am Senior Manager for the Neuroscience in Psychiatry Network (NSPN, £5.4m; www.nspn.org.uk). The first study 'U-Change' explores healthy neurodevelopment using a range of neuroscience techniques. The NCAAPS study will investigate patient cohorts with common mental health disorders. Other studies are interested in the immune system and brain function.

I am a Clinical Neuroscientist experienced in genetics, neuroimaging, and epigenetics. I extended my interests to examine social networking site data, in particular language use and culture amongst young people, in order to identify novel online social measures. I collaborate on clinical trials of the drug, EPO, in mood disorders. I am interested in how the human kinome maps to disease and health.

I am a co-founder of HIP HOP PSYCH (www.hiphoppsych.co.uk), which uses hip-hop as a vehicle for cultivating awareness about mental health, for public engagement, teaching innovation, refining psychotherapies and psychoeducation.

I am interested in learning how social networking site data, such as social network structure, can help us understand mental health conditions
I am interested in learning how social networking site data, such as social network structure, can help us understand mental health conditions
Click image to view full-size

Research Focus

Keywords

genetics

epigenetics

neuroimaging

psychosocial factors

environmental modulators

Clinical conditions

Addiction

Alzheimer's disease

Anxiety disorders

Attention deficit hyperactivity disorder

Autism

Autoimmune diseases

Bipolar disorder

Borderline personality disorder

Depressive disorders

Multiple sclerosis

Resiliency

Schizophrenia

Stress

Equipment

Behavioural analysis

Immunohistochemistry

Magnetic resonance imaging (MRI)

Neuropsychological testing

Randomised control trials

Turntables

Collaborators

No collaborators listed

Associated News Items


Key publications

Inkster B, Kosinski M, Stillwell D (in submission), “Neuroscience in the digital age” Nature Neuroscience

Inkster B, Stillwell D, Kosinski M, Jones P (in submission), “A decade into Facebook: where is psychiatry in the digital age?” The Lancet Psychiatry

Miskowiak KW, Vinberg M, Macoveanu J, Ehrenreich H, Køster N, Inkster B, Paulson OB, Kessing LV, Skimminge A, Siebner HR (2015), “Effects of Erythropoietin on Hippocampal Volume and Memory in Mood Disorders” Biol Psychiatry 78(4): 270-7

Sule A, Inkster B (2015), “Kendrick Lamar, street poet of mental health” The Lancet Psychiatry 2(6): 496-7

Publications

in submission

Inkster B, Simmons A, Cole J, Schoof E, Linding R, Nichols T, Whitcher B, Muglia P, Rao A, Auer DP, Holsboer F, Saemann P, McGuffin P, Fu C, Zai G, Miskowiak KW, Matthews PM, Nicodemus K (in submission), “Replicated epistasis relates to GSK3beta, hippocampal volume and major depressive disorder” Molecular Psychiatry

Inkster B, Zai G, Lewis G, Miskowiak KW (in submission), “GSK3β: a plausible mechanism of hippocampal change induced by erythropoietin treatment in mood disorders” Molecular Psychiatry

2015

Inkster B Sule A (2015), “Drug term trends in American hip-hop lyrics ” Journal of Public Mental Health 14(3): 169-173

Toseeb U, Inkster B (2015), “Online social networking sites and mental health research” Front Psychiatry 6(36): 1-4

2014

Sule A, Inkster B (2014), “A hip-hop state of mind” The Lancet Psychiatry 1(7):494-5

2013

Inkster B, Strijbis EM, Vounou M, Kappos L, Radue EW, Matthews PM, Uitdehaag BM, Barkhof F, Polman CH, Montana G, Geurts JJ (2013), “Histone deacetylase gene variants predict brain volume changes in multiple sclerosis.” Neurobiol Aging 34(1):238-47 Details

Strijbis EM, Inkster B, Vounou M, Naegelin Y, Kappos L, Radue EW, Matthews PM, Uitdehaag BM, Barkhof F, Polman CH, Montana G, Geurts JJ (2013), “Glutamate gene polymorphisms predict brain volumes in multiple sclerosis.” Mult Scler 19(3):281-8 Details

Weiskopf N, Suckling J, Williams G, Correia MM, Inkster B, Tait R, Ooi C, Bullmore ET, Lutti A (2013), “Quantitative multi-parameter mapping of R1, PD(*), MT, and R2(*) at 3T: a multi-center validation.” Front Neurosci 7:95 Details

2012

Coghlan S, Horder J, Inkster B, Mendez MA, Murphy DG, Nutt DJ (2012), “GABA system dysfunction in autism and related disorders: from synapse to symptoms.” Neurosci Biobehav Rev 36(9):2044-55 Details

Inkster B, Rao AW, Ridler K, Filippini N, Whitcher B, Nichols TE, Wetten S, Gibson RA, Borrie M, Kertesz A, Guzman DA, Loy-English I, Williams J, Saemann PG, Auer DP, Holsboer F, Tozzi F, Muglia P, Merlo-Pich E, Matthews PM (2012), “Genetic variation in GOLM1 and prefrontal cortical volume in Alzheimer's disease.” Neurobiol Aging 33(3):457-65 Details

2011

Dixson L, Ridler K, Nichols TE, Saemann PG, Auer DP, Holsboer F, Muglia P, Matthews PM, Inkster B (2011), “Thyroid hormone transporter genes and grey matter changes in patients with major depressive disorder and healthy controls.” Psychoneuroendocrinology 36(6):929-34 Details

Inkster B, Rao AW, Ridler K, Nichols TE, Saemann PG, Auer DP, Holsboer F, Tozzi F, Muglia P, Merlo-Pich E, Matthews PM (2011), “Structural brain changes in patients with recurrent major depressive disorder presenting with anxiety symptoms.” J Neuroimaging 21(4):375-82 Details

2010

Inkster B, Nichols TE, Saemann PG, Auer DP, Holsboer F, Muglia P, Matthews PM (2010), “Pathway-based approaches to imaging genetics association studies: Wnt signaling, GSK3beta substrates and major depression.” Neuroimage 53(3):908-17 Details

Miskowiak KW, Favaron E, Hafizi S, Inkster B, Goodwin GM, Cowen PJ, Harmer CJ (2010), “Erythropoietin modulates neural and cognitive processing of emotional information in biomarker models of antidepressant drug action in depressed patients.” Psychopharmacology (Berl) 210(3):419-28 Details

2009

Inkster B, Nichols TE, Saemann PG, Auer DP, Holsboer F, Muglia P, Matthews PM (2009), “Association of GSK3beta polymorphisms with brain structural changes in major depressive disorder.” Arch Gen Psychiatry 66(7):721-8 Details

Miskowiak KW, Favaron E, Hafizi S, Inkster B, Goodwin GM, Cowen PJ, Harmer CJ (2009), “Effects of erythropoietin on emotional processing biases in patients with major depression: an exploratory fMRI study.” Psychopharmacology (Berl) 207(1):133-42 Details

2008

Mannie ZN, Norbury R, Murphy SE, Inkster B, Harmer CJ, Cowen PJ (2008), “Affective modulation of anterior cingulate cortex in young people at increased familial risk of depression.” Br J Psychiatry 192(5):356-61 Details

Miskowiak K, Inkster B, O'Sullivan U, Selvaraj S, Goodwin GM, Harmer CJ (2008), “Differential effects of erythropoietin on neural and cognitive measures of executive function 3 and 7 days post-administration.” Exp Brain Res 184(3):313-21 Details

Miskowiak K, Inkster B, Selvaraj S, Wise R, Goodwin GM, Harmer CJ (2008), “Erythropoietin improves mood and modulates the cognitive and neural processing of emotion 3 days post administration.” Neuropsychopharmacology 33(3):611-8 Details

2007

Miskowiak K, Inkster B, Selvaraj S, Goodwin G, Harmer C (2007), “Erythropoietin has no effect on hippocampal response during memory retrieval 3 days post-administration.” Psychopharmacology (Berl) 195(3):451-3 Details

2004

Inkster B, Muglia P, Jain U, Kennedy JL (2004), “Linkage disequilibrium analysis of the dopamine beta-hydroxylase gene in persistent attention deficit hyperactivity disorder.” Psychiatr Genet 14(2):117-20 Details

2002

Muglia P, Jain U, Inkster B, Kennedy JL (2002), “A quantitative trait locus analysis of the dopamine transporter gene in adults with ADHD.” Neuropsychopharmacology 27(4):655-62 Details